These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2236481)

  • 1. In vitro colony culture and chromosomal studies in hepatic and portal vein thrombosis--possible evidence of an occult myeloproliferative state.
    Pagliuca A; Mufti GJ; Janossa-Tahernia M; Eridani S; Westwood NB; Thumpston J; Sawyer B; Sturgess R; Williams R
    Q J Med; 1990 Sep; 76(281):981-9. PubMed ID: 2236481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis.
    De Stefano V; Teofili L; Leone G; Michiels JJ
    Semin Thromb Hemost; 1997; 23(5):411-8. PubMed ID: 9387199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Budd-Chiari syndrome associated with chronic myeloproliferative syndromes: analysis of 6 cases].
    Cobo F; Cervantes F; García-Pagán JC; Bosch J; Rozman C; Montserrat E
    Med Clin (Barc); 1996 Nov; 107(17):660-3. PubMed ID: 9064408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Budd-Chiari syndrome and portal vein thrombosis associated with myeloproliferative disorders: diagnosis and management.
    Brière JB
    Semin Thromb Hemost; 2006 Apr; 32(3):208-18. PubMed ID: 16673275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Portal vein and hepatic vein thrombosis in occult myeloproliferative syndrome. Progression of thrombosis under heparin therapy].
    Frey HR; Suter B
    Schweiz Med Wochenschr; 1996 Aug; 126(34):1437-41. PubMed ID: 8848706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematological causes of venous thrombosis in young people: high incidence of myeloproliferative disorder as underlying disease in patients with splanchnic venous thrombosis.
    Teofili L; De Stefano V; Leone G; Micalizzi P; Iovino MS; Alfano G; Bizzi B
    Thromb Haemost; 1992 Mar; 67(3):297-301. PubMed ID: 1641818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome.
    Valla D; Casadevall N; Lacombe C; Varet B; Goldwasser E; Franco D; Maillard JN; Pariente EA; Leporrier M; Rueff B
    Ann Intern Med; 1985 Sep; 103(3):329-34. PubMed ID: 4026081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.
    Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF
    Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The JAK2(V617F) tyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis.
    Goulding C; Uttenthal B; Foroni L; Duke V; Traore A; Kottaridis P; Hoffbrand AV; Patch D; McNamara C
    Int J Lab Hematol; 2008 Oct; 30(5):415-9. PubMed ID: 19046316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis.
    Chait Y; Condat B; Cazals-Hatem D; Rufat P; Atmani S; Chaoui D; Guilmin F; Kiladjian JJ; Plessier A; Denninger MH; Casadevall N; Valla D; Brière JB
    Br J Haematol; 2005 May; 129(4):553-60. PubMed ID: 15877740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous erythroid colony formation in patients with retinal vein occlusion.
    Héron E; Marzac C; Feldman-Billard S; Girmens JF; Paques M; Delarue R; Piette JC; Casadevall N; Hermine O
    Ophthalmology; 2007 Dec; 114(12):2155-61. PubMed ID: 18054634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Budd-Chiari syndrome: a common complication of Behçet's disease.
    Bayraktar Y; Balkanci F; Bayraktar M; Calguneri M
    Am J Gastroenterol; 1997 May; 92(5):858-62. PubMed ID: 9149201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of the prevalence of factor V Leiden mutation in portal or hepatic vein thrombosis.
    Denninger MH; Helley D; Valla D; Guillin MC
    Thromb Haemost; 1997 Oct; 78(4):1297-8. PubMed ID: 9365003
    [No Abstract]   [Full Text] [Related]  

  • 14. Portal or hepatic vein thrombosis as the first presentation of a myeloproliferative disorder in patients with normal peripheral blood counts.
    McNamara C; Juneja S; Wolf M; Grigg A
    Clin Lab Haematol; 2002 Aug; 24(4):239-42. PubMed ID: 12181028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis.
    Gianelli U; Iurlo A; Cattaneo D; Bossi A; Cortinovis I; Augello C; Moro A; Savi F; Castelli R; Brambilla C; Bianchi P; Primignani M; Cortelezzi A; Bosari S
    Leuk Res; 2015 May; 39(5):525-9. PubMed ID: 25840747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythaemia.
    Florensa L; Besses C; Woessner S; Solé F; Acín P; Pedro C; Sans-Sabrafen J
    Leukemia; 1995 Feb; 9(2):271-3. PubMed ID: 7869763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders.
    Valla D; Casadevall N; Huisse MG; Tulliez M; Grange JD; Muller O; Binda T; Varet B; Rueff B; Benhamou JP
    Gastroenterology; 1988 Apr; 94(4):1063-9. PubMed ID: 3345875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors.
    Denninger MH; Chaït Y; Casadevall N; Hillaire S; Guillin MC; Bezeaud A; Erlinger S; Briere J; Valla D
    Hepatology; 2000 Mar; 31(3):587-91. PubMed ID: 10706547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 25-year clinical history of portopulmonary hypertension associated with latent myeloproliferative disorder.
    Ito H; Adachi Y; Arimura Y; Endo T; Hinoda Y; Imai K
    J Gastroenterol; 2003; 38(5):488-92. PubMed ID: 12768393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of erythroid progenitors to recombinant growth factors in the diagnosis of myeloproliferative disorders.
    Dudley JM; Westwood N; Woodcock S; Pearson TC; Eridani S
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():199-202. PubMed ID: 2324555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.